Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
40 studies found for:    University of Kentucky | Alzheimer's disease | United States, Kentucky
Show Display Options
Rank Status Study
1 Active, not recruiting Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Condition: Alzheimer Disease
Interventions: Drug: alphatocopherol;   Drug: Selenium;   Drug: Placebo replacement for vitamin E;   Drug: Placebo replacement for Selenium
2 Not yet recruiting Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
Condition: Preclinical Alzheimer's Disease
Interventions: Drug: Gemfibrozil;   Drug: Placebo
3 Active, not recruiting Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study
Condition: Alzheimer's Disease
Interventions: Drug: Valproic Acid;   Drug: Placebo
4 Terminated A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
5 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
6 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
7 Completed Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
Conditions: Memory Disorders;   Alzheimer Disease;   Dementia;   Cognitive Impairment;   Frontotemporal Dementia
Intervention: Device: COGNISION™ System
8 Completed Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.
Condition: Alzheimer's Disease
Intervention:
9 Active, not recruiting Alzheimer's Disease Neuroimaging Initiative 2
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease
Intervention:
10 Completed Resveratrol for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol;   Drug: Placebo
11 Completed Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Intervention:
12 Completed ADNI: Alzheimer's Disease Neuroimaging Initiative
Condition: Alzheimer's Disease
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Procedure: Positron Emission Tomography (PET);   Procedure: Lumbar Puncture (LP)
13 Completed Anti-Oxidant Treatment of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Vitamin E, Vitamin C, and Alpha-lipoic Acid;   Drug: Coenzyme Q;   Drug: Placebo capsules;   Drug: Placebo wafers
14 Completed Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
Condition: Alzheimer Disease
Intervention: Drug: Simvastatin
15 Completed A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
Condition: Alzheimer Disease
Interventions: Drug: Rofecoxib;   Drug: Naproxen
16 Recruiting Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
Condition: Alzheimer's Disease
Intervention: Drug: T-817MA
17 Completed Agitation in Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Trazodone;   Drug: Haloperidol
18 Completed Study of Melatonin: Sleep Problems in Alzheimer's Disease
Conditions: Alzheimer Disease;   Dyssomnias
Intervention: Drug: Melatonin
19 Completed Home-Based Assessment for Alzheimer Disease Prevention
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Behavioral: Mail and Live Phone;   Behavioral: Interactive Voice Response (IVR);   Behavioral: Home-based Computer Kiosk;   Behavioral: Traditional Evaluation Instruments
20 Recruiting The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Drug: Insulin (Humulin® R U-100);   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years